Search - tctmd.com

Displaying 21 - 40 of 47

Sort: Relevancy | Date

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

Presentation TCT 2023

TCT 149: Severe Pulmonary Artery Hypertension and Rheumatic Disease: Long-Term Follow-UP After Percutaneous Mitral Balloon Commissurotomy

Presenter: Rafael Alexandre Meneguz-Moreno

October 25, 2023

Presentation TCT 2023

TCT 148: Percutaneous Mitral Balloon Commissurotomy and Restenosis Due to Rheumatic Disease: Single-center Experience

Presenter: Rafael Alexandre Meneguz-Moreno

October 25, 2023

News Conference News THT 2023

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

Caitlin E. Cox

March 21, 2023

News Daily News

Top Structural Heart News of 2022

L.A. McKeown

January 06, 2023

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2022

Shelley Wood

September 01, 2022

News Conference News ESC 2022

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

Michael O'Riordan

August 28, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Conference News AHA 2021

AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients

L.A. McKeown

November 13, 2021

News Daily News

TAVI Matches SAVR in Older US Patients With Rheumatic Aortic Stenosis

Caitlin E. Cox

April 05, 2021

News Daily News

Echo Screening for Rheumatic Heart Disease in Kids Gets a Boost

Caitlin E. Cox

January 21, 2021

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Caitlin E. Cox

December 23, 2020

News Conference News AHA 2020

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

Todd Neale

November 14, 2020

Presentation TVT 2019

Transapical Closure of a Bioprosthetic Mitral Perivalvular Leak in a Patient With a History of Rheumatic Heart Disease and Severe Right-Sided Heart Failure

Presenter: Peter Petropulos

June 14, 2019

News Conference News EHRA 2019

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

Todd Neale

March 25, 2019

News Industry News

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

March 14, 2019

News Daily News

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

Todd Neale

March 12, 2019

News Opinion Conversations in Cardiology

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

November 16, 2018

Advertisement

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

TCT 149: Severe Pulmonary Artery Hypertension and Rheumatic Disease: Long-Term Follow-UP After Percutaneous Mitral Balloon Commissurotomy

TCT 148: Percutaneous Mitral Balloon Commissurotomy and Restenosis Due to Rheumatic Disease: Single-center Experience

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

Top Structural Heart News of 2022

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

TCTMD’s Top 10 Most Popular Stories for August 2022

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

What’s Going to Be Hot at ESC 2022?

AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients

TAVI Matches SAVR in Older US Patients With Rheumatic Aortic Stenosis

Echo Screening for Rheumatic Heart Disease in Kids Gets a Boost

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

Transapical Closure of a Bioprosthetic Mitral Perivalvular Leak in a Patient With a History of Rheumatic Heart Disease and Severe Right-Sided Heart Failure

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content